- Home
- JSPR vs DXYZ Comparison
JSPR vs DXYZ Comparison
Compare JSPR & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- DXYZ
- Stock Information
- Founded
- JSPR 2018
- DXYZ N/A
- Country
- JSPR United States
- DXYZ
- Employees
- JSPR N/A
- DXYZ N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- DXYZ
- Sector
- JSPR Health Care
- DXYZ
- Exchange
- JSPR Nasdaq
- DXYZ Nasdaq
- Market Cap
- JSPR 302.0M
- DXYZ 350.2M
- IPO Year
- JSPR N/A
- DXYZ 2024
- Fundamental
- Price
- JSPR $20.43
- DXYZ $32.26
- Analyst Decision
- JSPR Strong Buy
- DXYZ
- Analyst Count
- JSPR 10
- DXYZ 0
- Target Price
- JSPR $74.86
- DXYZ N/A
- AVG Volume (30 Days)
- JSPR 279.1K
- DXYZ N/A
- Earning Date
- JSPR 11-07-2024
- DXYZ N/A
- Dividend Yield
- JSPR N/A
- DXYZ N/A
- EPS Growth
- JSPR N/A
- DXYZ N/A
- EPS
- JSPR N/A
- DXYZ N/A
- Revenue
- JSPR N/A
- DXYZ N/A
- Revenue This Year
- JSPR N/A
- DXYZ N/A
- Revenue Next Year
- JSPR N/A
- DXYZ N/A
- P/E Ratio
- JSPR N/A
- DXYZ N/A
- Revenue Growth
- JSPR N/A
- DXYZ N/A
- 52 Week Low
- JSPR $4.00
- DXYZ N/A
- 52 Week High
- JSPR $31.01
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- JSPR 45.73
- DXYZ N/A
- Support Level
- JSPR $22.00
- DXYZ N/A
- Resistance Level
- JSPR $24.90
- DXYZ N/A
- Average True Range (ATR)
- JSPR 1.69
- DXYZ 0.00
- MACD
- JSPR -0.17
- DXYZ 0.00
- Stochastic Oscillator
- JSPR 11.52
- DXYZ 0.00
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.